Evidence map›Paper›PMID 42618800›Full record

ArticleThe EMBO journal2026

Anchoring of perforin-2 via the transmembrane domain is required for antigen escape into the cytosol.

Marco Laub, Ritika Chatterjee, Patrycja Kozik

Abstract read
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marco LaubMRC Laboratory of Molecular Biology, Cambridge, UK.
Ritika ChatterjeeMRC Laboratory of Molecular Biology, Cambridge, UK.
Patrycja KozikMRC Laboratory of Molecular Biology, Cambridge, UK. pkozik@mrclmb.ac.uk.ORCID http://orcid.org/0000-0001-8596-843X

Funding

UK Research and Innovation (UKRI) MC_UP_1201/26
6 · The paper itself

Abstract

Perforin-2 is a pore-forming protein localised to the endocytic compartments of dendritic cells and macrophages. It is reported to perform two distinct functions during immune responses: attacking intravacuolar pathogens, and forming pores in endocytic compartments to enable cytosolic delivery of antigens during cross-presentation. The molecular mechanisms that regulate perforin-2 remain unknown. Here, we address how cross-presenting dendritic cells control pore formation in phagosomes while maintaining the integrity of their endocytic compartments. We demonstrate that perforin-2 undergoes extensive proteolytic processing involving multiple endocytic proteases. Although the transmembrane anchor has been proposed to protect host membranes by orienting pores towards bacterial targets, we find that endocytic escape is mediated by full-length, membrane-anchored perforin-2 rather than by the proteolytically released ectodomain. Moreover, we show that perforin-2-mediated antigen translocation does not require low pH, explaining how perforin-2 can form pores in cross-presenting dendritic cells which do not acidify their phagosomes. Our findings point to a critical role of the transmembrane anchor in perforin-2 biology and suggest that perforin-2 employs distinct mechanisms of pore formation during anti-bacterial defence and cross-presentation.

Indexed as

CytosolDendritic CellsPore Forming Cytotoxic ProteinsAnimalsCross-PrimingMicePhagosomesProtein Domainsperforin 2Pore Forming Cytotoxic Proteins

Identifiers

PMID42618800
PMCPMC13631362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.